Abstract:1. Introduction 310 2. Protein-only hypothesis 312 3. The scrapie prion protein PrP Sc 313 3.1 Purification of PrP 27–30 313 3.2 Proteinase K resistance 314 3.3 Scrapie-associated fibrils 314 3.4 Smallest infectious unit 316 3.5 Conformational properties 316 3.6 Dissociation and stability 319 4. The cellular prion protein PrP C 321 4.1 Prnp expression 321 4.2 Biosynthetic pathway 322 4.3 NMR structures 324 4.4 Copper binding 326 5. Post-translational PrP conversion 327 5.1 Conformational isoforms 327 5.2 Location of propagation 329 5.3 Minimal PrP sequence 330 5.4 Prion species barrier 331 5.5 Prion strains 332 6. Effect of familial TSE mutations 333 6.1 Thermodynamic stability of PrP C 334 6.2 De novo synthesis of PrP Sc 335 6.3 Transmembrane PrP forms 337 7. Physical properties of synthetic PrP 337 7.1 Amyloidogenic peptides 337 7.2 Folding intermediates 339 8. Hypothetical protein X 340 8.1 Two species-specific epitopes 340 8.2 Mapping the protein X epitope 341 9. Chaperone-mediated PrP conversion 343 9.1 Hsp60 and Hsp10 chaperonins 343 9.2 GroEL promoted PrP-res formation 345 9.3 Membrane-associated chaperonins 345 9.4 Preference of GroEL for positive charges 347 9.5 Potential GroEL/Hsp60 epitopes on PrP 347 9.6 Conformations of chaperonin-bound PrP 349 9.7 Conserved Hsp60 substrate binding sites 349 9.8 Requirement of ATP-hydrolysis 351 9.9 Hsp60-mediated prion propagation 354 10. Template-assisted annealing model 355 11. Acknowledgments 357 12. References 357 Although the central paradigm of protein folding (Anfinsen, 1973), that the unique three-dimensional structure of a protein is encoded in its amino acid sequence, is well established, its generality has been questioned due to two recent developments in molecular biology, the ‘prion’ and ‘molecular chaperone’. Biochemical characterization of infectious scrapie material causing central nervous system (CNS) degeneration indicates that the necessary component for disease propagation is proteinaceous (Prusiner, 1982), as first outlined by Griffith (1967) in general terms, and involves a conversion from a cellular prion protein, denoted PrP C , into a toxic scrapie form, PrP Sc , which is facilitated by PrP Sc acting as a template for PrP C to form new PrP Sc molecules (Prusiner, 1987). The ‘protein-only’ hypothesis implies that the same polypeptide sequence, in the absence of any post-translational modifications, can adopt two considerably different stable protein conformations (Fig. 1). Thus, in the case of prions it is possible, although not proven, that they violate the central paradigm of protein folding. There is some indirect evidence that another factor, provisionally named ‘protein X’, might be involved in the conformational conversion process (Prusiner et al . 1998), which includes a dramatic change from α-helical into β-sheet secondary structure (Fig. 1). This factor has not been identified yet, but it has been proposed that protein X may act as a molecular chaperone. The idea that molecular chaperones play a critical role in the generation of PrP Sc is appealing also from a theoretical point of view, because PrP Sc formation involves changes in protein folding and possibly intermolecular aggregation (Fig. 1), processes in which chaperones are known to participate (Musgrove & Ellis, 1986). The discovery and functional analysis of more than a dozen molecular chaperones made it clear that these proteins do not complement folding information that is not already contained in the genetic code (Ellis et al . 1989); rather they facilitate the folding and assembly of proteins by preventing misfolding and refolding misfolded proteins (Hartl, 1996). Whether a molecular chaperone or another type of macromolecule is identified as the conversion factor, therefore, the molecular chaperone concept is likely to contribute to the understanding of the molecular nature of PrP C to PrP Sc conversion. In this review I consider the prion concept from the view of a structural biologist whose main interest focuses on spontaneous and chaperone-mediated conformational changes in proteins.

An electrostatic-interaction-based mechanism triggering misfolding of prion proteins from cellular isoform to scrapie isoform

Comparison of the Unfolding and Oligomerization of Human Prion Protein under Acidic and Neutral Environments by Molecular Dynamics Simulations

The Folding Mechanism And Key Metastable State Identification Of The Prp127-147 Monomer Studied By Molecular Dynamics Simulations And Markov State Model Analysis

Expression of PrP(C) As HIS-fusion Form in a Baculovirus System and Conversion of Expressed PrP-sen to PrP-res in a Cell-Free System.

Infection of Prions and Treatment of PrP106–126 Alter the Endogenous Status of Protein 14-3-3 and Trigger the Mitochondrial Apoptosis Possibly via Activating Bax Pathway

Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents

Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations.

Discovery of small molecules binding to the normal conformation of prion by combining virtual screening and multiple biological activity evaluation methods

Interaction Between 14-3-3β and PrP Influences the Dimerization of 14-3-3 and Fibrillization of PrP106-126.

Prion propagation and molecular chaperones

Structural and dynamical determinants of a β-sheet-enriched intermediate involved in amyloid fibrillar assembly of human prion protein

In Situ Molecular-Level Insights into the Interfacial Structure Changes of Membrane-Associated Prion Protein Fragment [118-135] Investigated by Sum Frequency Generation Vibrational Spectroscopy.

PrP(Sc) of Scrapie 263K Propagates Efficiently in Spleen and Muscle Tissues with Protein Misfolding Cyclic Amplification.

Model Study of Prionlike Folding Behavior in Aggregated Proteins

A Transient Intermediate Populated in Prion Folding Leads to Domain Swapping

Experimental and Theoretical Insights into the Inhibition Mechanism of Prion Fibrillation by Resveratrol and Its Derivatives

Protein-lipid interactions and protein anchoring modulate the modes of association of the globular domain of the Prion protein and Doppel protein to model membrane patches

Folding Pathways of Prion and Doppel

Cell-Free Conversion of Prion Proteins

The allure and pitfalls of the prion-like aggregation in neurodegeneration

Structural and Dynamic Properties of the Human Prion Protein.